7:08 AM
Jan 10, 2019
 |  BC Extra  |  Financial News

NEA, RA Capital lead $85M B round for Black Diamond

Editor's Note: This article was updated on Jan 10, 2019 at 4:32 PM PST

Less than a month after its launch by Versant Ventures, Black Diamond Therapeutics Inc. (Cambridge, Mass.) has raised a tranched $85 million series B round to bring its two lead assets into the clinic and prepare it for an IPO in about...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >